Head of Health Economics & Market Access, Surgery - Germany

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com.

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Wir arbeiten seit einem Jahrhundert an der Seite von Ärzten und Patienten, um das Gesundheitswesen immer wieder aufs Neue zu verbessern und zu optimieren sowie neu zu denken.  Unser J&J-MedTech-Portfolio wird von Innovationen geprägt, die Barrieren an der Schnittstelle zwischen Biologie und Technologie aus dem Weg räumen.

Gemeinsam entwickeln wir die nächste Generation intelligenter, weniger invasiver und personalisierter Lösungen, um die größten und komplexesten gesundheitlichen Herausforderungen für Menschen auf der ganzen Welt zu bekämpfen.

Begleiten Sie uns auf unserem Weg, während wir Medizinprodukte weiterentwickeln und den Übergang von der Forschung ins echte Leben ermöglichen – immer im engen Austausch mit unseren Patienten, um sie bei jedem Schritt zu unterstützen.

Weitere Informationen finden Sie unter https://www.jnj.com/medtech

Health Economics & Market Access (HEMA) is a critical component of our strategy for achieving sustainable access and growth in an increasingly complex healthcare environment. The Associate Director and Head of HEMA Germany is the senior country leader accountable for setting the HEMA vision and strategy, leading the department and its talent, and ensuring that health-economic and market-access priorities are embedded in business decisions for the Surgery portfolio. The role owns the development and execution of market access, reimbursement, evidence-generation and market-development strategies; provides authoritative counsel to senior management; and represents the organisation with external decision-makers. Through disciplined prioritisation, cross-functional leadership and effective deployment of resources, the role will deliver measurable access and business outcomes in Germany.

• →Advanced degree in health economics, health policy, public health, economics, healthcare management, epidemiology, outcomes research, or other relevant discipline

• →Deep expertise in HTA, health economics, reimbursement and market access, with the judgement to translate technical evidence into strategic business decisions.
• →Strong track record of influencing senior internal and external stakeholders and securing alignment in complex, high-stakes environments.
• →At least 7, preferred 10 years of experience, of progressive experience in MedTech, pharmaceuticals, an HTA or payer organisation, healthcare consultancy, academia, outcomes research or another relevant healthcare-system setting, including substantial experience operating at senior strategic level. Prior MedTech and German market experience are strongly preferred.
• →Expert understanding of the German healthcare system, payer landscape, funding pathways, procurement environment and relevant policy developments.
• →Demonstrated breadth and depth of market access and health-economics experience, with evidence of leading strategic decisions rather than solely delivering technical work.
• →Proven people-leadership experience with direct accountability for building, leading and developing teams, setting direction, managing performance, coaching senior talent and succession planning.
• →Demonstrated executive presence and ability to lead through influence, challenge constructively and secure decisions across a senior cross-functional matrix.
• →Strong portfolio leadership and governance capabilities, with the ability to prioritise competing investments, manage risk and drive complex programmes to measurable outcomes.
• →Ability to critically assess and synthesise clinical and health-economic evidence and convert it into clear executive recommendations and compelling value narratives.
• →Demonstrated accountability for delivering strategic objectives through cross-functional teams, within agreed budgets, timelines, governance and compliance standards.
• →Sound judgement, independence and resilience, with the ability to make decisions under ambiguity and take ownership of their consequences.
• →Exceptional communication and influencing skills, with credibility to represent HEMA with executive leaders, customers, payers and external institutions.

• Experience of engagement with payers
• Familiarity with healthcare systems database sources
• Track record of overcoming complex market access challenges
• Experience of strategic planning that is aligned with priority projects to achieve excellence in execution
• Previous experience of developing business cases, value briefs and value propositions to support market access strategies
• Experience of delivering reimbursement and HTA information to internal sales & marketing teams
• Ability to critically assess and synthesize clinical, epidemiological, real-world and health-economic evidence.